The largest database of trusted experimental protocols

Fix perm and perm wash solution

Manufactured by BD

FIX/PERM and PERM/Wash solution are laboratory products used in various applications. FIX/PERM solution is a fixative, while PERM/Wash solution is used for washing purposes. The core function of these products is to facilitate specific laboratory procedures, but a detailed description without interpretation or extrapolation cannot be provided.

Automatically generated - may contain errors

2 protocols using fix perm and perm wash solution

1

Detecting VP11/12-specific CD8+ T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect VP11/12-specific cytolytic CD8+ T cells in PBMC, spleen, TG and cornea cells, intracellular CD107a/b cytotoxicity assay was performed as described by Betts et al. (2003) with a few modifications (37 (link), 38 (link)). Briefly, 1×106 PBMCs from patients, in addition to spleen cells, DLN cells and TG cells from HSV-infected mice infected, were transferred into 96-well V-bottomed FACS plates (BD) in R10 medium and stimulated with 10 different VP11/12 peptides (10 μg/mL) in the presence of anti-CD107a-FITC and CD107b-FITC (BD PHArmingen) and BD-Golgi stop (10μg /ml) for 5–6 hours at 37°C. PHA (10 μg/mL) (Sigma) and no peptide were used as positive and negative controls, respectively. At the end of the incubation period, the cells were harvested into separate tubes and washed once with FACS buffer and then stained with PE-conjugated anti-human CD8 antibody for 30 minutes. Cells were then fixed, permeabilized and stained with additional antibodies against IFN-γ and TNF- α using FIX/PERM and PERM/Wash solution (BD).
+ Open protocol
+ Expand
2

Detecting VP11/12-specific Cytolytic CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect VP11/12-specific cytolytic CD8+ T cells in PBMC and cornea cells, intracellular CD107a/b cytotoxicity assay was performed as described by Betts et al. with a few modifications (25 (link), 26 (link)). Briefly, 1×106 PBMCs from patients, in addition to spleen cells, DLN cells and TG cells from mice infected with HSV, were transferred into 96-well V bottom FACS plates (BD) in R10 medium and stimulated with 10 different VP11/12 peptides (10μg/mL) in the presence of anti-CD107a-FITC and CD107b-FITC (BD Pharmingen) and BD-Golgi stop (10ug/ml) for 5–6 hours at 37°C. ConA (10μg/mL) (Sigma) and no peptide were used as positive and negative controls, respectively. At the end of the incubation period the cells were harvested into separate tubes and washed once with FACS buffer and then stained with PE-conjugated anti-human CD8 antibody for 30 min. Cells were fixed, permeabilized, and stained with additional antibodies against IFN-γ using FIX/PERM and PERM/Wash solution (BD).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!